This study was supported in part by the National Institute of Blood Transfusion (INTS), the National Institute for Health and Medical Research (INSERM), and Paris Diderot University (Paris 7).
BLOOD GROUP GENOMICS
Family study of a Swiss patient uncovered a novel genetic basis for the S−s−U+var phenotype
Article first published online: 17 APR 2014
© 2014 AABB
Volume 54, Issue 11, pages 2941–2945, November 2014
How to Cite
Saison, C., Waldvogel, S., Gien, D., Peyrard, T. and Arnaud, L. (2014), Family study of a Swiss patient uncovered a novel genetic basis for the S−s−U+var phenotype. Transfusion, 54: 2941–2945. doi: 10.1111/trf.12681
- Issue published online: 10 NOV 2014
- Article first published online: 17 APR 2014
- Manuscript Accepted: 6 MAR 2014
- Manuscript Revised: 5 MAR 2014
- Manuscript Received: 21 JAN 2014
- National Institute of Blood Transfusion (INTS)
- National Institute for Health and Medical Research (INSERM)
- Paris Diderot University (Paris 7)
The rare S−s− phenotype is typically found in persons of African origin. Three genetic bases underlying this phenotype have been identified so far: a large deletion including the GYPB gene, which encodes the S and s antigens, and two mutations affecting GYPB splicing (commonly called “P2” and “NY”). The discovery of the S−s− phenotype in a Swiss patient prompted this study.
Study Design and Methods
The GYPB genotype of the patient was analyzed with Beadchip technology and Sanger sequencing. GYPB haplotype analysis was also carried out in the patient's family. A functional splicing assay was developed to determine the impact of the identified mutation on GYPB splicing.
Sanger sequencing of GYPB in the patient indicated that she was homozygous for a GYPB*s allele carrying a novel mutation in the splice donor site of Intron 5 (c.270+5G>A). Analysis of GYPB haplotypes in the patient's family revealed that she actually inherited this mutated GYPB*s allele from her mother of Swiss ancestry and a deleted GYPB allele from her father of Egyptian ancestry. Using a minigene-based splicing assay, we showed that GYPB mutation c.270+5G>A causes the skipping of Exon B5, as previously reported for the P2 mutation (c.270+5G>T). Consistently, the patient's red blood cells were found to be S−s−U+var.
A novel GYPB mutation (c.270+5G>A) accounting for the S−s−U+var phenotype was identified. In contrast with P2 and NY mutations, which also drive this rare phenotype, this novel GYPB mutation inactivates a GYPB*s allele and does not appear to be of African origin.